News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,593 Results
Type
Article (43418)
Company Profile (345)
Press Release (666830)
Section
Business (211972)
Career Advice (2161)
Deals (37029)
Drug Delivery (102)
Drug Development (83912)
Employer Resources (173)
FDA (16611)
Job Trends (15530)
News (359166)
Policy (34330)
Tag
Academia (2610)
Alliances (51672)
Alzheimer's disease (1245)
Approvals (16518)
Artificial intelligence (131)
Bankruptcy (368)
Best Places to Work (11682)
Biotechnology (217)
Breast cancer (111)
Cancer (949)
Cardiovascular disease (88)
Career advice (1800)
Cell therapy (209)
Clinical research (66361)
Collaboration (341)
Compensation (173)
COVID-19 (2617)
Data (876)
Diabetes (144)
Diagnostics (6214)
Drug pricing (95)
Earnings (86309)
Employer resources (152)
Events (112964)
Executive appointments (256)
FDA (17065)
Funding (300)
Gene therapy (163)
GLP-1 (629)
Government (4507)
Healthcare (18988)
Infectious disease (2698)
Inflammatory bowel disease (108)
Interviews (337)
IPO (16707)
Job creations (4156)
Job search strategy (1548)
Layoffs (444)
Legal (8457)
Lung cancer (164)
Manufacturing (165)
Medical device (13285)
Medtech (13290)
Mergers & acquisitions (20334)
Metabolic disorders (414)
Neuroscience (1502)
NextGen Class of 2024 (6713)
Non-profit (4538)
Northern California (1230)
Obesity (248)
Opinion (219)
Patents (101)
People (58614)
Pharmaceutical (101)
Phase I (20601)
Phase II (29155)
Phase III (21876)
Pipeline (215)
Postmarket research (2673)
Preclinical (8714)
Radiopharmaceuticals (243)
Rare diseases (195)
Real estate (6347)
Regulatory (22621)
Research institute (2381)
Resumes & cover letters (370)
Southern California (1097)
Startups (3779)
United States (11993)
Vaccines (568)
Weight loss (202)
Date
Today (236)
Last 7 days (869)
Last 30 days (3096)
Last 365 days (36692)
2024 (31356)
2023 (40936)
2022 (52119)
2021 (56677)
2020 (55115)
2019 (47834)
2018 (36143)
2017 (33574)
2016 (33172)
2015 (39015)
2014 (32966)
2013 (28086)
2012 (30170)
2011 (30873)
2010 (28890)
Location
Africa (804)
Arizona (196)
Asia (40866)
Australia (6478)
California (2794)
Canada (1190)
China (216)
Colorado (121)
Connecticut (127)
Europe (87372)
Florida (403)
Georgia (100)
Illinois (319)
Indiana (190)
Kansas (95)
Maryland (529)
Massachusetts (2306)
Michigan (145)
Minnesota (252)
New Jersey (847)
New York (848)
North Carolina (709)
Northern California (1230)
Ohio (129)
Pennsylvania (752)
South America (1179)
Southern California (1097)
Texas (398)
Washington State (332)
710,593 Results for "evoke pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI® nasal spray, announced updates regarding their business and commercial growth strategy.
June 17, 2024
·
9 min read
Business
Evoke Pharma Reports First Quarter 2024 Financial Results
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced its financial results for the first quarter ended March 31, 2024, and recent corporate developments.
May 14, 2024
·
11 min read
Press Releases
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
October 23, 2024
·
4 min read
Press Releases
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
August 8, 2024
·
10 min read
Press Releases
Evoke Pharma, Inc. Announces Reverse Stock Split
July 30, 2024
·
5 min read
Press Releases
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
August 13, 2024
·
12 min read
Biotech Beach
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Evoke Pharma, Inc. announced it will host a virtual KOL and investor webinar on Wednesday, April 24 at 12:00 p.m. ET.
April 17, 2024
·
5 min read
Press Releases
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
October 1, 2024
·
4 min read
Press Releases
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
October 24, 2024
·
2 min read
Business
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Evoke Pharma, Inc. (NASDAQ: EVOK) today announced that the Company is scheduled to release its fourth quarter and full year 2023 on Thursday, March 14, 2024, after the market closes.
March 7, 2024
·
6 min read
1 of 71,060
Next
